Relmada Therapeutics, Inc. RLMD Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Relmada Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed August 7, 2024, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s debt-to-equity?
- Relmada Therapeutics, Inc. (RLMD) reported debt-to-equity of 0.9× in Q2 2023.
- How has Relmada Therapeutics, Inc.'s debt-to-equity changed year-over-year?
- Relmada Therapeutics, Inc.'s debt-to-equity increased by 5.3% year-over-year, from 0.9× to 0.9×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.